WallStSmart
TIL

Instil Bio Inc.

NASDAQ: TIL · HEALTHCARE · BIOTECHNOLOGY

$8.10
-0.86% today

Updated 2026-06-05

Market cap
$53.78M
P/E ratio
P/S ratio
54,248.82x
EPS (TTM)
$-7.00
Dividend yield
52W range
$6 – $35
Volume
0.0M

Instil Bio Inc. (TIL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2019202020212022202320242025
Revenue$0.00$138000.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)-100.0%
Cost of revenue$20000.00$2.75M$5.99M$4.76M$3.61M$534000.00
Gross profit$-20000.00$138000.00$-2.75M$-5.99M$-4.76M$-3.61M$-534000.00
Gross margin100.0%
R&D$4.03M$19.40M$107.25M$141.06M$39.60M$11.84M$10.00M
SG&A$2.56M$14.38M$48.31M$62.23M$47.55M$44.21M$27.22M
Operating income$-6.58M$-33.64M$-155.56M$-206.17M$-159.17M$-73.54M$-52.91M
Operating margin-24379.7%
EBITDA$-6.50M$-33.39M$-152.81M$-217.38M$-147.12M$-62.53M$-65.01M
EBITDA margin-24194.2%
EBIT$-6.52M$-33.64M$-155.56M$-223.37M$-151.87M$-66.14M$-65.54M
Interest expense$0.00$3.30M$1.56M$1.88M$5.21M$8.99M$5.83M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-6.45M$-37.74M$-156.79M$-223.18M$-156.09M$-74.14M$-71.37M
Net income growth (YoY)-484.7%-315.5%-42.3%+30.1%+52.5%+3.7%
Profit margin-27346.4%

Frequently asked questions

How much free cash flow does TIL generate?

TIL produced $-46.62M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is TIL's balance sheet healthy?

TIL holds $6.64M in cash and equivalents against $84.81M in long-term debt, on $113.87M of shareholder equity. That debt is best read against the cash flow the business throws off each year.